- Home
- SOHO vs ITRM Comparison
SOHO vs ITRM Comparison
Compare SOHO & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- ITRM
- Stock Information
- Founded
- SOHO 2004
- ITRM 2015
- Country
- SOHO United States
- ITRM Ireland
- Employees
- SOHO N/A
- ITRM N/A
- Industry
- SOHO Real Estate Investment Trusts
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- ITRM Health Care
- Exchange
- SOHO Nasdaq
- ITRM Nasdaq
- Market Cap
- SOHO 27.2M
- ITRM 24.7M
- IPO Year
- SOHO 2004
- ITRM 2018
- Fundamental
- Price
- SOHO $1.01
- ITRM $1.70
- Analyst Decision
- SOHO Hold
- ITRM Strong Buy
- Analyst Count
- SOHO 1
- ITRM 1
- Target Price
- SOHO $1.50
- ITRM $5.00
- AVG Volume (30 Days)
- SOHO 126.6K
- ITRM 7.1M
- Earning Date
- SOHO 11-12-2024
- ITRM 11-14-2024
- Dividend Yield
- SOHO N/A
- ITRM N/A
- EPS Growth
- SOHO N/A
- ITRM N/A
- EPS
- SOHO N/A
- ITRM N/A
- Revenue
- SOHO $179,860,606.00
- ITRM N/A
- Revenue This Year
- SOHO N/A
- ITRM N/A
- Revenue Next Year
- SOHO $0.70
- ITRM N/A
- P/E Ratio
- SOHO N/A
- ITRM N/A
- Revenue Growth
- SOHO 3.98
- ITRM N/A
- 52 Week Low
- SOHO $0.97
- ITRM $0.81
- 52 Week High
- SOHO $1.65
- ITRM $2.50
- Technical
- Relative Strength Index (RSI)
- SOHO 35.82
- ITRM 65.72
- Support Level
- SOHO $1.02
- ITRM $1.25
- Resistance Level
- SOHO $1.09
- ITRM $1.61
- Average True Range (ATR)
- SOHO 0.07
- ITRM 0.13
- MACD
- SOHO -0.03
- ITRM 0.02
- Stochastic Oscillator
- SOHO 2.50
- ITRM 98.19
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.